Novare Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-11,503
| Closed | -$1.28M | – | 176 |
|
|
2022
Q1 | $1.28M | Sell |
11,503
-76,856
| -87% | -$8.12M | 0.14% | 95 |
|
|
2021
Q4 | $9.14M | Sell |
88,359
-725
| -0.8% | -$84K | 0.93% | 45 |
|
|
2021
Q3 | $11.2M | Buy |
89,084
+1,596
| +2% | +$207K | 1.24% | 25 |
|
|
2021
Q2 | $10.9M | Buy |
87,488
+2,153
| +3% | +$270K | 1.21% | 26 |
|
|
2021
Q1 | $10.1M | Buy |
85,335
+2,044
| +2% | +$240K | 1.21% | 29 |
|
|
2020
Q4 | $9.76M | Sell |
83,291
-1,624
| -2% | -$179K | 1.27% | 24 |
|
|
2020
Q3 | $8.82M | Buy |
84,915
+1,524
| +2% | +$153K | 1.24% | 27 |
|
|
2020
Q2 | $7.65M | Sell |
83,391
-2,710
| -3% | -$260K | 1.14% | 28 |
|
|
2020
Q1 | $7.76M | Sell |
86,101
-1,967
| -2% | -$209K | 1.37% | 21 |
|
|
2019
Q4 | $9.99M | Buy |
88,068
+455
| +0.5% | +$49.9K | 1.39% | 18 |
|
|
2019
Q3 | $9.52M | Sell |
87,613
-2,297
| -3% | -$240K | 1.41% | 18 |
|
|
2019
Q2 | $8.76M | Buy |
89,910
+608
| +0.7% | +$55.5K | 1.33% | 21 |
|
|
2019
Q1 | $8.13M | Sell |
89,302
-1,046
| -1% | -$93.6K | 1.27% | 26 |
|
|
2018
Q4 | $8.22M | Sell |
90,348
-1,694
| -2% | -$158K | 1.5% | 17 |
|
|
2018
Q3 | $9.05M | Sell |
92,042
-149
| -0.2% | -$13.8K | 1.44% | 18 |
|
|
2018
Q2 | $7.89M | Buy |
92,191
+90
| +0.1% | +$7.52K | 1.34% | 21 |
|
|
2018
Q1 | $7.39M | Buy |
92,101
+3,320
| +4% | +$274K | 1.29% | 21 |
|
|
2017
Q4 | $7.17M | Buy |
88,781
+2,282
| +3% | +$183K | 1.22% | 24 |
|
|
2017
Q3 | $6.73M | Sell |
86,499
-1,153
| -1% | -$95.7K | 1.18% | 29 |
|
|
2017
Q2 | $7.78M | Sell |
87,652
-694
| -0.8% | -$58.5K | 1.75% | 10 |
|
|
2017
Q1 | $7.12M | Buy |
88,346
+5,651
| +7% | +$441K | 1.65% | 15 |
|
|
2016
Q4 | $5.89M | Buy |
82,695
+9,706
| +13% | +$763K | 1.45% | 23 |
|
|
2016
Q3 | $6.31M | Sell |
72,989
-2,926
| -4% | -$255K | 1.65% | 15 |
|
|
2016
Q2 | $6.59M | Sell |
75,915
-1,678
| -2% | -$136K | 1.78% | 13 |
|
|
2016
Q1 | $5.82M | Sell |
77,593
-2,468
| -3% | -$186K | 1.63% | 19 |
|
|
2015
Q4 | $6.16M | Buy |
80,061
+283
| +0.4% | +$21.3K | 1.68% | 20 |
|
|
2015
Q3 | $5.34M | Buy |
79,778
+1,503
| +2% | +$111K | 1.47% | 25 |
|
|
2015
Q2 | $5.8M | Buy |
78,275
+5,481
| +8% | +$419K | 1.43% | 31 |
|
|
2015
Q1 | $5.68M | Buy |
72,794
+65,284
| +869% | +$4.95M | 1.41% | 31 |
|
|
2014
Q4 | $542K | Buy |
7,510
+2,160
| +40% | +$150K | 0.13% | 87 |
|
|
2014
Q3 | $331K | Buy |
+5,350
| New | +$340K | 0.08% | 102 |
|
Other funds holding MDT
Novare Capital Management's MDT Position: Q2 2022 in Review
Novare Capital Management sold out of Medtronic (MDT) in Q2 2022, closing a stake of 11,503 shares — an estimated $1.28M sold.
Novare Capital Management first reported a position in MDT in Q3 2014 and held it in 31 quarters. The position peaked at $11.2M in Q3 2021. 2,022 funds tracked by Wall St. Rank hold MDT as of Q2 2022.
- Novare Capital Management reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
- Novare Capital Management sold 11,503 Medtronic shares in Q2 2022, an estimated $1.28M.
- Novare Capital Management first reported a position in Medtronic in Q3 2014 and held it in 31 quarters.
- Novare Capital Management's Medtronic position peaked at $11.2M in Q3 2021.
- 2,022 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.
Based on Novare Capital Management's 13F filing for Q2 2022, filed 3 Aug 2022.